Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
03 04 2023
Historique:
medline: 5 4 2023
pubmed: 12 11 2022
entrez: 11 11 2022
Statut: epublish

Résumé

Sub-Saharan Africa has the highest rates of cervical cancer in the world, largely attributed to low cervical cancer screening coverage. Cervical cancer is the most common cause of death among women in 21 of the 48 countries in sub-Saharan Africa. Close to 100% of all cases of cervical cancer are attributable to Human papillomavirus (HPV). HPV types 16 and 18 cause at least 70% of all cervical cancers globally, while types 31, 33, 45, 52, and 58 cause a further 20% of the cases. Women living with HIV are six times more likely to develop cervical cancer than those without HIV. Considering that sub-Saharan Africa carries the greatest burden of cervical cancer, ways to increase accessibility and use of preventive services are urgently required. With this review, we discuss the preventive measures required to reduce the burden of cervical cancer in sub-Saharan Africa, the challenges to improving accessibility and use of the preventive services, and the recommendations to address these challenges.

Identifiants

pubmed: 36368710
pii: ijgc-2022-003957
doi: 10.1136/ijgc-2022-003957
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

592-597

Informations de copyright

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Tafadzwa Dzinamarira (T)

Department of Public Health, University of Pretoria, Pretoria, South Africa u19395419@up.ac.za.
ICAP at Columbia University, Harare, Zimbabwe.

Enos Moyo (E)

Department of Public Health, Oshakati Medical Centre, Oshakati, Namibia.

Mathias Dzobo (M)

Department of Public Health, University of Pretoria, Pretoria, South Africa.

Elliot Mbunge (E)

Department of Information Technology, University of Eswatini, Kwaluseni, Swaziland.

Grant Murewanhema (G)

Unit of Obstetrics and Gynaecology, University of Zimbabwe, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH